These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 11865423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.
    Stowers AW, Cioce V, Shimp RL, Lawson M, Hui G, Muratova O, Kaslow DC, Robinson R, Long CA, Miller LH.
    Infect Immun; 2001 Mar; 69(3):1536-46. PubMed ID: 11179324
    [Abstract] [Full Text] [Related]

  • 3. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [Abstract] [Full Text] [Related]

  • 4. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.
    Stowers AW, Chen Lh LH, Zhang Y, Kennedy MC, Zou L, Lambert L, Rice TJ, Kaslow DC, Saul A, Long CA, Meade H, Miller LH.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):339-44. PubMed ID: 11752405
    [Abstract] [Full Text] [Related]

  • 5. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR, Narum DL, Gozalo AS, Aguiar J, Fuhrmann SR, Liang H, Haynes JD, Moch JK, Lucas C, Luu T, Magill AJ, Hoffman SL, Sim BK.
    J Infect Dis; 2001 Jan 15; 183(2):303-312. PubMed ID: 11110648
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S, Yadava A, Keister DB, Tian JH, Ohl M, Perdue-Greenfield KA, Miller LH, Kaslow DC.
    Mol Med; 1995 Mar 15; 1(3):325-32. PubMed ID: 8529111
    [Abstract] [Full Text] [Related]

  • 7. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
    Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, Hitt SL, McBride JS, Diggs CL, Holder AA, Long CA, Barnwell JW, Lyon JA.
    Infect Immun; 2005 Jan 15; 73(1):287-97. PubMed ID: 15618165
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 9. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.
    Stowers AW, Kennedy MC, Keegan BP, Saul A, Long CA, Miller LH.
    Infect Immun; 2002 Dec 15; 70(12):6961-7. PubMed ID: 12438375
    [Abstract] [Full Text] [Related]

  • 10. Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants.
    Carvalho LJ, Alves FA, Bianco C, Oliveira SG, Zanini GM, Soe S, Druilhe P, Theisen M, Muniz JA, Daniel-Ribeiro CT.
    Clin Diagn Lab Immunol; 2005 Feb 15; 12(2):242-8. PubMed ID: 15699417
    [Abstract] [Full Text] [Related]

  • 11. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
    Egan AF, Blackman MJ, Kaslow DC.
    Infect Immun; 2000 Mar 15; 68(3):1418-27. PubMed ID: 10678955
    [Abstract] [Full Text] [Related]

  • 12. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO, Keegan B, Long CA, Miller LH.
    J Infect Dis; 2006 Mar 01; 193(5):731-40. PubMed ID: 16453270
    [Abstract] [Full Text] [Related]

  • 13. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
    Perlaza BL, Valencia AZ, Zapata C, Castellanos A, Sauzet JP, Blanc C, Cohen J, Arévalo-Herrera M, Corradin G, Herrera S, Druilhe P.
    Eur J Immunol; 2008 Sep 01; 38(9):2610-5. PubMed ID: 18792413
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P, Ruebush TK, Campbell GH, Richman SJ, Wilkins PP, Broderson JR, Ardeshir F, Gross M, Silverman C, Skinner JC.
    Am J Trop Med Hyg; 1992 Jun 01; 46(6):691-707. PubMed ID: 1621894
    [Abstract] [Full Text] [Related]

  • 15. Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line.
    Baruch DI, Gamain B, Barnwell JW, Sullivan JS, Stowers A, Galland GG, Miller LH, Collins WE.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3860-5. PubMed ID: 11904437
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa.
    Sirima SB, Nébié I, Ouédraogo A, Tiono AB, Konaté AT, Gansané A, Dermé AI, Diarra A, Ouédraogo A, Soulama I, Cuzzin-Ouattara N, Cousens S, Leroy O.
    Vaccine; 2007 Mar 30; 25(14):2723-32. PubMed ID: 17280744
    [Abstract] [Full Text] [Related]

  • 17. The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas.
    Jepsen MP, Jogdand PS, Singh SK, Esen M, Christiansen M, Issifou S, Hounkpatin AB, Ateba-Ngoa U, Kremsner PG, Dziegiel MH, Olesen-Larsen S, Jepsen S, Mordmüller B, Theisen M.
    J Infect Dis; 2013 Aug 01; 208(3):479-88. PubMed ID: 23624363
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure.
    Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL, Lambert L, Miller LH, Long CA, Saul A, Narum DL.
    Mol Biochem Parasitol; 2009 Mar 01; 164(1):45-56. PubMed ID: 19073223
    [Abstract] [Full Text] [Related]

  • 19. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge.
    Obaldia N, Stockelman MG, Otero W, Cockrill JA, Ganeshan H, Abot EN, Zhang J, Limbach K, Charoenvit Y, Doolan DL, Tang DC, Richie TL.
    Clin Vaccine Immunol; 2017 Apr 01; 24(4):. PubMed ID: 28179404
    [Abstract] [Full Text] [Related]

  • 20. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B, Hundt E, Knapp B.
    Mem Inst Oswaldo Cruz; 1992 Apr 01; 87 Suppl 3():413-22. PubMed ID: 1343721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.